JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB33905

Anti-Bcl10 antibody [EP606Y]

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Recombinant Monoclonal BCL10 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 7 publications.

View Alternative Names

CIPER, CLAP, BCL10, B-cell lymphoma/leukemia 10, B-cell CLL/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, Cellular-E10, Mammalian CARD-containing adapter molecule E10, Bcl-10, hCLAP, cCARMEN, c-E10, mE10

10 Images
Flow Cytometry (Intracellular) - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Bcl10 antibody [EP606Y] (AB33905)

Intracellular Flow Cytometry analysis of Raji (human Burkitt's lymphoma) cells labeling Bcl10 (red) with ab33905 at a 1/200 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with primary and secondary antibodies.

Immunocytochemistry/ Immunofluorescence - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Bcl10 antibody [EP606Y] (AB33905)

Immunofluorescence staining of Raji cells with purified ab33905 at a working dilution of 1/100, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 4 % PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab33905 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl10 antibody [EP606Y] (AB33905)

Unpurified ab33905, at a 1/100 dilution, staining human hepatocellular carcinoma by Immunohistochemistry, Paraffin embedded tissue.

Immunocytochemistry/ Immunofluorescence - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Bcl10 antibody [EP606Y] (AB33905)

Unpurified ab33905, staining HeLa cells by Immunofluorescent.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl10 antibody [EP606Y] (AB33905)

Immunohistochemical staining of paraffin embedded human lung carcinoma with purified ab33905 at a working dilution of 1/50. The secondary antibody used is ab97051, a goat anti-rabbit IgG (H&L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.

Immunoprecipitation - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • IP

Unknown

Immunoprecipitation - Anti-Bcl10 antibody [EP606Y] (AB33905)

ab33905 (purified) at 1/20 immunoprecipitating Bcl10 in 10 μg Ramos cell lysate (Lanes 1 and 2, observed at 32 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730). For western blotting, HRP Veriblot for IP (ab131366) was used for detection (1/10 000). Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST

All lanes:

Immunoprecipitation - Anti-Bcl10 antibody [EP606Y] (ab33905)

Predicted band size: 26 kDa

false

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • WB

Lab

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Bcl10 antibody [EP606Y] (ab33905) at 1/5000 dilution

Lane 1:

Raji cell lysate at 20 µg

Lane 2:

Ramos cell lysate at 20 µg

Lane 3:

HuT-78 cell lysate at 20 µg

Lane 4:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 26 kDa

Observed band size: 32 kDa

false

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • WB

Lab

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)

Lanes 1-4 : Merged signal (red and green). Green - ab33905 observed at 32 kDa. Red - loading control, ab7291 observed at 52 kDa.

ab33905 Anti-Bcl10 antibody [EP606Y] was shown to specifically react with Bcl10 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261797 (knockout cell lysate ab257144) was used. Wild-type and Bcl10 knockout samples were subjected to SDS-PAGE. ab33905 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl10 antibody [EP606Y] (ab33905) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human BCL10 knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-bcl10-knockout-hela-cell-lysate-ab257144'>ab257144</a>)

Lane 3:

Ramos cell lysate at 20 µg

Lane 4:

A549 cell lysate at 20 µg

Predicted band size: 26 kDa

Observed band size: 32 kDa

false

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • WB

Lab

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)

Lanes 1-4 : Merged signal (red and green). Green - ab33905 observed at 32 kDa. Red - loading control, ab7291 observed at 52 kDa.

ab33905 Anti-Bcl10 antibody [EP606Y] was shown to specifically react with Bcl10 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261797 (knockout cell lysate ab257144) was used. Wild-type and Bcl10 knockout samples were subjected to SDS-PAGE. ab33905 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl10 antibody [EP606Y] (ab33905) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

BCL10 knockout HeLa cell lysate at 20 µg

Lane 3:

Ramos cell lysate at 20 µg

Lane 4:

A549 cell lysate at 20 µg

Predicted band size: 26 kDa

Observed band size: 32 kDa

false

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)
  • WB

Unknown

Western blot - Anti-Bcl10 antibody [EP606Y] (AB33905)

All lanes:

Western blot - Anti-Bcl10 antibody [EP606Y] (ab33905) at 1/1000 dilution

All lanes:

Recombinant Human Bcl10 protein (<a href='/en-us/products/unavailable/recombinant-human-bcl10-protein-ab82241'>ab82241</a>) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

Predicted band size: 26 kDa

true

Exposure time: 1min

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP606Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, Flow Cyt (Intra), IHC-P, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20 - 1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/200", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/20 - 1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bcl10 also known as B-cell lymphoma 10 is a protein involved in several cellular processes. It has a molecular mass of approximately 26 kDa and shows expression in various lymphoid tissues. Bcl10 plays a significant role in signaling pathways by transmitting signals from the cell surface to the nucleus impacting cell growth and immune responses. Researchers often study Bcl10 using immunohistochemistry (IHC) techniques referred to as Bcl10 IHC to analyze its expression and distribution within tissues.
Biological function summary

Bcl10 activates downstream signaling pathways that are critical for immune cell functioning and survival. It forms part of the CARD-BCL10-MALT1 (CBM) complex which is important for the activation of the NF-kB pathway. This complex formation is essential for lymphocyte activation and proliferation. Bcl10 interactions within this complex influence cellular responses to various stimuli helping organisms to mount appropriate immune responses.

Pathways

Bcl10 serves as an integral component in the NF-kB and TCR signaling pathways. It functions alongside proteins such as MALT1 and CARD9 in these pathways. The proper functioning of Bcl10 in these pathways ensures accurate transcriptional regulation necessary for immune responses. Misregulation in these pathways can lead to immune disorders and aberrant cell behavior linking Bcl10 to further biological implications.

Bcl10 shows associations with mucosa-associated lymphoid tissue (MALT) lymphoma and other inflammatory diseases. Aberrant Bcl10 expression or mutations can lead to unchecked activation of NF-kB contributing to the progression of these conditions. In MALT lymphoma Bcl10 often cooperates with MALT1 both contributing to pathological cell survival and proliferation highlighting the importance of Bcl10 in understanding these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation (PubMed : 10187770, PubMed : 10364242, PubMed : 10400625, PubMed : 24074955, PubMed : 25365219). Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed : 24074955). Recruited by activated CARD domain-containing proteins : homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex (PubMed : 24074955). This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed : 18287044, PubMed : 24074955, PubMed : 27777308). Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity (PubMed : 26488816). Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR) (PubMed : 18264101, PubMed : 18287044, PubMed : 24074955, PubMed : 27777308). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK (PubMed : 10187815).
See full target information BCL10

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Autophagy 19:678-691 PubMed35838483

2022

Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in .

Applications

Unspecified application

Species

Unspecified reactive species

Guowu Hu,Pia J Hauk,Nannan Zhang,Waleed Elsegeiny,Carlos M Guardia,Amy Kullas,Kevin Crosby,Robin R Deterding,Michaela Schedel,Paul Reynolds,Jordan K Abbott,Vijaya Knight,Stefania Pittaluga,Mark Raffeld,Sergio D Rosenzweig,Juan S Bonifacino,Gulbu Uzel,Peter R Williamson,Erwin W Gelfand

Nature communications 13:2169 PubMed35449156

2022

Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohan Shi,Yunguang Li,Qiuyue Yuan,Shijie Tang,Shiwei Guo,Yehan Zhang,Juan He,Xiaoyu Zhang,Ming Han,Zhuang Liu,Yiqin Zhu,Suizhi Gao,Huan Wang,Xiongfei Xu,Kailian Zheng,Wei Jing,Luonan Chen,Yong Wang,Gang Jin,Dong Gao

Cell reports 29:873-888.e10 PubMed31644910

2019

MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Torben Gehring,Tabea Erdmann,Marco Rahm,Carina Graß,Andrew Flatley,Thomas J O'Neill,Simone Woods,Isabel Meininger,Ozge Karayel,Kerstin Kutzner,Michael Grau,Hisaaki Shinohara,Katja Lammens,Regina Feederle,Stefanie M Hauck,Georg Lenz,Daniel Krappmann

Immunology and cell biology 96:81-99 PubMed29359407

2018

The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Maureen Bardet,Adeline Unterreiner,Claire Malinverni,Frédérique Lafossas,Corinne Vedrine,Danielle Boesch,Yeter Kolb,Daniel Kaiser,Anton Glück,Martin A Schneider,Andreas Katopodis,Martin Renatus,Oliver Simic,Achim Schlapbach,Jean Quancard,Catherine H Régnier,Guido Bold,Carole Pissot-Soldermann,José M Carballido,Jiri Kovarik,Thomas Calzascia,Frédéric Bornancin

PloS one 12:e0169026 PubMed28052131

2017

Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.

Applications

WB

Species

Unspecified reactive species

Stefanie Ginster,Maureen Bardet,Adeline Unterreiner,Claire Malinverni,Florian Renner,Stephen Lam,Felix Freuler,Bertran Gerrits,Johannes Voshol,Thomas Calzascia,Catherine H Régnier,Martin Renatus,Rainer Nikolay,Laura Israël,Frédéric Bornancin

Nature communications 7:11292 PubMed27068814

2016

Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells.

Applications

Unspecified application

Species

Mouse

Isabel Meininger,Richard A Griesbach,Desheng Hu,Torben Gehring,Thomas Seeholzer,Arianna Bertossi,Jan Kranich,Andrea Oeckinghaus,Andrea C Eitelhuber,Ute Greczmiel,Andreas Gewies,Marc Schmidt-Supprian,Jürgen Ruland,Thomas Brocker,Vigo Heissmeyer,Florian Heyd,Daniel Krappmann

Journal of neuroinflammation 11:124 PubMed25043939

2014

Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.

Applications

WB

Species

Mouse

Conor Mc Guire,Lynn Elton,Peter Wieghofer,Jens Staal,Sofie Voet,Annelies Demeyer,Daniel Nagel,Daniel Krappmann,Marco Prinz,Rudi Beyaert,Geert van Loo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com